Risk Minimisation Study for Diane-35 and Its Generics
Status:
Completed
Trial end date:
2016-03-04
Target enrollment:
Participant gender:
Summary
The study will be an observational, cross-sectional study of knowledge, understanding, and
self-reported behavior among a sample of physicians with recent experience in prescribing
Diane-35 or its generics in a total of five European countries. The primary objective of this
study is to measure physician knowledge and understanding of the key information contained in
the Diane-35 educational material: Patient information card, and Prescribers' Checklist.
Specifically, the following objectives will be addressed:
- Investigate whether physicians have received any educational material related to
Diane-35 or its generics
- Assess physicians' knowledge and understanding of key safety information pertaining to
the patient information card
- Assess physicians' knowledge and understanding of key safety information pertaining to
the following areas:
- Contraindications relevant to thromboembolism
- Risk factors for thromboembolism
- Signs and symptoms of thromboembolism